EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid nanoparticles adjuvanted with poly(I:C) enhance respiratory mucosal immunity induced by a protein subunit vaccine

Tasson da Costa Rodrigues, Naga Suresh Kola, Dhruv Patel, Alaa Ibrahim, Shamsuddeen Yusuf Ma'aruf, Azita Haddadi, Mark Fenton, Gabriel Kristian Pedersen, Jeffrey M Chen, Neeraj Dhar, Aneesh Thakur

European Journal of Pharmaceutics and Biopharmaceutics · 2026-11 · 115289

DOI: 10.1016/j.ejpb.2026.115289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-11. Verfasst von Tasson da Costa Rodrigues und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3, Canada. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saskatchewan Health Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subunit vaccines are typically given through injections, which limits mucosal immunity. Most adjuvants do not stimulate mucosal responses but using lipid nanoparticles (LNPs) encapsulating polyinosinic-polycytidylic acid (poly(I:C)), a toll-like receptor 3 agonist, could enhance the immune response in the lungs. We tested LNPs made from four ionizable lipids using a microfluidic mixing method to encapsulate poly(I:C) at different concentrations. The LNPs were evaluated for particle size, polydispersity index (PDI), poly(I:C) encapsulation efficiency (EE %), morphology, and NF-κB activation over a 4-week period. Mice were immunized with LNPs containing poly(I:C) and a protein antigen from Mycobacterium tuberculosis via the intrapulmonary route. Results showed that LNPs formulated with low molecular weight poly(I:C) exhibited the most favorable physicochemical properties and higher NF-κB induction compared to those made with high molecular weight poly(I:C), although a statistically significant difference was only observed for PDI. LNPs made with the ionizable lipid SM-102 were the most stable. Immunized mice had enhanced levels of serum and mucosal antibodies. Notably, the most prominent effect of the poly(I:C)-LNPs was the generation of significant cytokine-producing cells in the lungs and spleen, alongside memory cells in the lungs, spleen, and lymph nodes. In conclusion, pulmonary immunization with poly(I:C)-LNPs induced both systemic and mucosal immunity, though further investigation into antigen-specific protection is necessary. Overall, this work demonstrates new possibilities for vaccine development against respiratory infections.

Schlagwörter

Stichwörter der Autor:innen

AdjuvantIgALipid nanoparticlesProtein subunit vaccineResident memory T cellsRespiratory mucosal immunitypoly(I:C)

Autor:innen und Institutionen

  • Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3, Canada.
  • Division of Pharmacy, College of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, Saskatchewan S7N 5E5, Canada.
  • Division of Respirology, Critical Care and Sleep Medicine, Respiratory Research Centre, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, Saskatchewan S7N 5E5, Canada.
  • Department of Infectious Disease Immunology, Center for Vaccine Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark; Novo Nordisk Foundation Initiative for Vaccines and Immunity, NIVI Research C…
  • Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3, Canada; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan,…
  • Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3, Canada; Division of Pharmacy, College of Pharmacy and Nutrition, University of Saskatchewan,…

Förderung

  • Saskatchewan Health Research Foundation

Zitieren

APA

da Costa Rodrigues, T., Kola, N. S., Patel, D., Ibrahim, A., Ma'aruf, S. Y., Haddadi, A., Fenton, M., Pedersen, G. K., Chen, J. M., Dhar, N., & Thakur, A. (2026). Lipid nanoparticles adjuvanted with poly(I:C) enhance respiratory mucosal immunity induced by a protein subunit vaccine. European Journal of Pharmaceutics and Biopharmaceutics, 115289. https://doi.org/10.1016/j.ejpb.2026.115289

Vancouver

da Costa Rodrigues T, Kola NS, Patel D, Ibrahim A, Ma'aruf SY, Haddadi A, et al. Lipid nanoparticles adjuvanted with poly(I:C) enhance respiratory mucosal immunity induced by a protein subunit vaccine. European Journal of Pharmaceutics and Biopharmaceutics. 2026:115289. doi:10.1016/j.ejpb.2026.115289

BibTeX
@article{daCostaRodrigues2026,
  author = {da Costa Rodrigues, Tasson and Kola, Naga Suresh and Patel, Dhruv and Ibrahim, Alaa and Ma'aruf, Shamsuddeen Yusuf and Haddadi, Azita and Fenton, Mark and Pedersen, Gabriel Kristian and Chen, Jeffrey M and Dhar, Neeraj and Thakur, Aneesh},
  title = {Lipid nanoparticles adjuvanted with poly(I:C) enhance respiratory mucosal immunity induced by a protein subunit vaccine},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  pages = {115289},
  doi = {10.1016/j.ejpb.2026.115289}
}
Kostenlos starten →